Selecta Biosciences, Inc.

480 Arsenal Street
Building One

Watertown, MA  02472

Tel: 617.923.1400


Leadership:
Werner Cautreels, Ph.D.
CEO


Website:
www.selectabio.com

Selecta Biosciences, Inc.

Flagship Partners:  Ed Kania
Initial Investment: 
2008
Status: 
Private

Selecta Biosciences, Inc. is a clinical-stage biotechnology company developing novel drugs that use immune modulating nanomedicines to generate targeted antigen-specific immune responses to prevent and treat disease. Selecta’s proprietary Synthetic Vaccine Particle (SVP) platform creates a novel paradigm in immunotherapeutics and vaccines, enabling completely new applications while offering the potential of improved efficacy and safety profiles.

Ed Kania is on the Board of Directors.